AstraZeneca eyes up transition to eco-friendly inhaler propellant

AstraZeneca has completed all clinical studies required to support the first filings for the transition of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri to a next-generation propellant (NGP) with near-zero global warming potential.